Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -89,876 | -67,039 | -42,024 | -20,929 | -85,077 |
| Depreciation Amortization | 133 | 84 | 44 | 20 | 62 |
| Accounts receivable | -3,976 | -4,245 | -1,875 | -2,250 | -918 |
| Accounts payable and accrued liabilities | 4,232 | 1,098 | -87 | 305 | -3,201 |
| Other Working Capital | 665 | -2,216 | -2,394 | -3,112 | -1,241 |
| Other Operating Activity | 19,680 | 18,794 | 11,610 | 6,564 | 11,331 |
| Operating Cash Flow | $-69,142 | $-53,524 | $-34,725 | $-19,404 | $-79,044 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -396 | -308 | -265 | -75 | -165 |
| Purchase Sale Intangibles | -845 | -542 | -393 | -91 | -419 |
| Other Investing Activity | -859 | -556 | -398 | -91 | -419 |
| Investing Cash Flow | $-1,256 | $-863 | $-663 | $-165 | $-584 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 137,226 | 137,216 | 137,215 | 136,960 | 92,973 |
| Financing Cash Flow | $137,226 | $137,216 | $137,215 | $136,960 | $92,973 |
| Beginning Cash Position | 64,706 | 64,706 | 64,706 | 64,706 | 51,362 |
| End Cash Position | 131,534 | 147,534 | 166,532 | 182,097 | 64,706 |
| Net Cash Flow | $66,828 | $82,828 | $101,826 | $117,391 | $13,345 |
| Free Cash Flow | |||||
| Operating Cash Flow | -69,142 | -53,524 | -34,725 | -19,404 | -79,044 |
| Capital Expenditure | -396 | -308 | -265 | -75 | -165 |
| Free Cash Flow | -69,539 | -53,832 | -34,990 | -19,478 | -79,209 |